Abstract
Myelodysplastic Syndrome (MDS) with normal karyotype (NK-MDS) represents ∼50% of all MDS. Chromosomal microarray (CMA) provides clinically important information in NK-MDS by uncovering cryptic copy-number aberrations (CNA) and copy-neutral loss-of-heterozygosity (CN-LOH). Data regarding the role of CN-LOH in AML progression in NK-MDS is scant.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
